Helix BioPharma Corp.
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada. Show More...
-
Website https://www.helixbiopharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.92 CAD
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-07 2011-07 2012-07 2013-07 2014-07 2015-07 2016-07 2017-07 2018-07 2019-07 TTM Earnings Per Share CAD -0.24 -0.17 -0.26 -0.02 -0.12 -0.11 -0.11 -0.11 -0.09 -0.07 -0.08 Dividends CAD Payout Ratio % * Shares Mil 59.0 65.0 67.0 67.0 71.0 79.0 86.0 92.0 100.0 107.0 116.0 Book Value Per Share * CAD 0.28 0.23 0.09 0.1 0.04 0.1 0.05 -0.02 -0.010 -0.02 Free Cash Flow Per Share * CAD -0.27 -0.22 -0.21 -0.09 -0.12 -0.1 -0.1 -0.11 -0.09 -0.06 Return on Assets % -77.31 -53.42 -108.94 -22.92 -126.55 -111.57 -157.62 -302.3 -517.4 -721.23 -439.55 Financial Leverage (Average) 1.15 1.1 1.22 1.19 1.15 1.14 1.41 23.82 Return on Equity % -88.16 -59.93 -122.97 -27.73 -148.02 -128.02 -193.47 -639.28 Return on Invested Capital % -88.38 -60.66 -123.73 -28.18 -148.43 -128.66 -193.65 -639.4 Interest Coverage -326.76 -455.95 -674.38 -567.53 -717.5 -296.41 545.06 Current Ratio 6.87 9.81 4.47 5.48 7.11 7.71 3.25 0.77 0.29 0.16 1.53 Quick Ratio 6.35 9.48 4.09 5.33 7.03 7.52 3.18 0.69 0.25 0.12 1.37 Debt/Equity